2 Results for "

Vevorisertib

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "Vevorisertib" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-137458A
CAS No.: 1416775-08-0
Purity:  99.13%
Synonyms: ARQ 751 trihydrochloride
Target:  

Akt

Research Areas:  

Cancer

Vevorisertib (ARQ 751) trihydrochloride is a selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitors. Vevorisertib trihydrochloride potently inhibit phosphorylation of AKT. Vevorisertib trihydrochloride has Kd values of 1.2 nM and 8.6 nM for AKT1 and AKT1-E17K, respectively. Vevorisertib trihydrochloride has IC50 values of 0.55, 0.81, and 1.3 nM for AKT1, AKT2, and AKT3, respectively. Vevorisertib trihydrochloride can be used for the research of cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-137458
CAS No.: 1416775-46-6
Purity:  98.03%
Synonyms: ARQ 751
Target:  

Akt Ser/Thr Protease

Research Areas:  

Cancer

Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). Vevorisertib, as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations .
loading...
    loading...